Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | $194M | $205M | $174M |
| Revenue growth | — | — | 6.1% | -15.5% |
| Gross profit | — | $137M | $156M | $127M |
| Gross margin | — | 70.9% | 76.0% | 73.3% |
| Operating income | — | $70.7M | $70.3M | $67.5M |
| Operating margin | — | 36.5% | 34.2% | 38.9% |
| Net income | — | $39.4M | $46.6M | $51.0M |
| Net margin | — | 20.3% | 22.7% | 29.4% |
| EPS (diluted) | — | $0.42 | $0.48 | $0.50 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | — | $50.7M | $20.6M | $24.7M |
| Capital expenditures | — | $8.54M | $2.56M | $1.40M |
| Free cash flow | — | $42.1M | $18.0M | $23.3M |
| Share buybacks | — | — | $0.00 | $5.00M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $486K | $103M | $125M | $164M |
| Total assets | $120M | $259M | $266M | $380M |
| Total liabilities | $4.59M | $115M | $71.1M | $117M |
| Long-term debt | — | — | $6.60M | $42.8M |
| Shareholders' equity | -$3.36M | $142M | $195M | $248M |
| Retained earnings | -$3.36M | $143M | $189M | $240M |
| Shares (wtd avg diluted) | — | 94.2M | 96.6M | 103M |
Every figure is extracted from SBC Medical Group Holdings Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.